| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G | 2024-03-29 | Frazier Life Sciences Public Fund, L.P. | PUMA BIOTECHNOLOGY, INC. | 1,295,100 | 2.7% | EDGAR |
| SC 13G/A | 2024-02-14 | Camber Capital Management LP | PUMA BIOTECHNOLOGY, INC. | - | - | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | PUMA BIOTECHNOLOGY, INC. | 3,802,081 | 8.0% | EDGAR |
| SC 13G/A | 2024-02-06 | ACORN BIOVENTURES, L.P. | PUMA BIOTECHNOLOGY, INC. | 1,232,490 | 2.6% | EDGAR |
| SC 13G/A | 2024-01-30 | MILLENNIUM MANAGEMENT LLC | PUMA BIOTECHNOLOGY, INC. | 2,843,239 | 6.0% | EDGAR |
| SC 13G | 2023-09-01 | ACORN BIOVENTURES, L.P. | PUMA BIOTECHNOLOGY, INC. | 1,150,774 | 2.4% | EDGAR |
| SC 13G/A | 2023-02-14 | Camber Capital Management LP | PUMA BIOTECHNOLOGY, INC. | - | - | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | PUMA BIOTECHNOLOGY, INC. | 3,588,922 | 7.9% | EDGAR |
| SC 13G/A | 2023-02-07 | GOLDMAN SACHS GROUP INC | PUMA BIOTECHNOLOGY, INC. | 396,136 | 0.9% | EDGAR |
| SC 13G/A | 2023-01-19 | MILLENNIUM MANAGEMENT LLC | PUMA BIOTECHNOLOGY, INC. | 2,676,913 | 5.8% | EDGAR |
| SC 13D/A | 2022-12-13 | AUERBACH ALAN H | PUMA BIOTECHNOLOGY, INC. | 10,195,990 | 20.5% | EDGAR |
| SC 13G | 2022-07-08 | BlackRock Inc. | PUMA BIOTECHNOLOGY, INC. | 1,903,137 | 4.2% | EDGAR |
| SC 13D/A | 2022-03-15 | AUERBACH ALAN H | PUMA BIOTECHNOLOGY, INC. | 9,347,277 | 21.0% | EDGAR |
| SC 13G/A | 2022-02-14 | Camber Capital Management LP | PUMA BIOTECHNOLOGY, INC. | - | - | EDGAR |
| SC 13G/A | 2022-02-11 | Flynn James E | PUMA BIOTECHNOLOGY, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-02-10 | STATE STREET CORP | PUMA BIOTECHNOLOGY, INC. | - | 1.4% | EDGAR |
| SC 13G/A | 2022-02-10 | VANGUARD GROUP INC | PUMA BIOTECHNOLOGY, INC. | 3,680,187 | 9.0% | EDGAR |
| SC 13G | 2022-02-08 | GOLDMAN SACHS GROUP INC | PUMA BIOTECHNOLOGY, INC. | 2,097,647 | 5.1% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | PUMA BIOTECHNOLOGY, INC. | 3,204,237 | 7.8% | EDGAR |
| SC 13G | 2022-01-14 | MILLENNIUM MANAGEMENT LLC | PUMA BIOTECHNOLOGY, INC. | 2,237,699 | 5.5% | EDGAR |